BILL NUMBER: AB 686	AMENDED
	BILL TEXT

	AMENDED IN ASSEMBLY  MAY 24, 2013
	AMENDED IN ASSEMBLY  MAY 7, 2013
	AMENDED IN ASSEMBLY  MARCH 19, 2013

INTRODUCED BY   Assembly Member Quirk

                        FEBRUARY 21, 2013

   An act to add and repeal Section 25201.18 of the Health and Safety
Code, relating to hazardous waste.


	LEGISLATIVE COUNSEL'S DIGEST


   AB 686, as amended, Quirk. Hazardous waste: pharmaceutical
facilities.
   Existing law requires hazardous waste facilities, including, but
not limited to, treatment facilities, to operate under hazardous
waste facilities permits or other grants of authorization issued by
the Department of Toxic Substances Control. Existing law exempts
pharmaceutical neutralization activities from certain requirements of
the hazardous waste control laws and certain regulations adopted
pursuant to that law if specified conditions are met with regard to
the pharmaceutical manufacturing or process development activities,
including the management of air emissions and wastes generated as a
result of those activities.
   This bill would require the department, by January 1, 
2015   2016  , to develop recommendations for
standards and guidelines for the operation of onsite waste management
and recycling of hazardous waste at facilities engaged in
pharmaceutical manufacturing or pharmaceutical process development.
The department would be required, by January 1,  2015
  2016  , to submit a report to the Legislature on
those recommendations, including any recommended statutory and
regulatory actions needed to assure the safe and efficient management
of waste from pharmaceutical manufacturing or pharmaceutical process
development  actives   activities  . The
bill would repeal this report requirement on January 1, 2019.
   Vote: majority. Appropriation: no. Fiscal committee: yes.
State-mandated local program: no.


THE PEOPLE OF THE STATE OF CALIFORNIA DO ENACT AS FOLLOWS:

  SECTION 1.  Section 25201.18 is added to the Health and Safety
Code, to read:
   25201.18.  (a) On or before January 1,  2015 
 2016  , the department shall develop recommendations for
standards and guidelines for the operation of onsite hazardous waste
management and recycling activities at facilities engaged in
pharmaceutical manufacturing or pharmaceutical process development.
The recommendations shall consider, but are not limited to, all of
the following:
   (1) Actions to reduce the production and offsite disposal of
hazardous waste from pharmaceutical manufacturing operations.
   (2) Actions to provide incentives to reduce greenhouse gas
emissions through increased energy efficiency.
   (3) Recommended permit conditions or other requirements for onsite
waste management within a pharmaceutical manufacturing facility to
ensure the protection of public health and the environment and that
recognize the unique federal and state requirements that apply to
pharmaceutical manufacturing.
   (b) On or before January 1,  2015   2016
 , the department shall submit a report to the Legislature in
compliance with Section 9795 of the Government Code on the
recommendations developed pursuant to subdivision (a), including any
recommended statutory and regulatory actions needed to assure the
safe and efficient management of hazardous waste from pharmaceutical
manufacturing or pharmaceutical process development activities.
   (c) This section shall remain in effect only until January 1,
2019, pursuant to Section 10231.5 of the Government Code and as of
that date is repealed, unless a later enacted statute, that is
enacted before January 1, 2019, deletes or extends that date.